Filings For: Lantern Pharma Inc.
WHO USES CALCBENCH?    Equity Analysts    Corparate Finance & Reporting    Auditors    Academics
GO TO: Recent Comment Letters


Today


ALL   |    All 10-K/Qs   Large   Mid    Small    Micro    |     Earnings Release    Proxy    |   SORT BY :   Most Recent    Company Name 
CompanyTimeSizeViewFinancialsDocumentSECPeriodRevenue MRQAssetsEPS Diluted
Lantern Pharma Inc. (LTRN) 8/14/2026 7:43:29 AM Micro View Financials 10-Q SEC 2Q 2026 ending: 6/30/2026 Assets $8,602,349 EPS -$0.57
Lantern Pharma Inc. (LTRN) 8/14/2026 7:37:56 AM   View Financials Earnings SEC 2Q 2026 Assets $8,602,349 EPS -$0.57 Export Earnings Model
Lantern Pharma Inc. (LTRN) 5/15/2026 4:13:50 PM Micro View Financials 10-Q SEC 1Q 2026 ending: 3/31/2026 Assets $7,223,067 EPS -$0.30
Lantern Pharma Inc. (LTRN) 5/15/2026 4:13:21 PM   View Financials Earnings SEC 1Q 2026 Assets $7,223,067 EPS -$0.30 Export Earnings Model
Lantern Pharma Inc. (LTRN) 4/30/2026 6:38:46 AM Micro View Financials 10-K/A SEC Y 2025 ending: 12/31/2025 Assets $11,035,811 EPS -$1.57
Lantern Pharma Inc. (LTRN) 3/30/2026 6:26:34 PM   View Financials Earnings SEC Y 2025 Assets $11,035,811 EPS -$0.36 Export Earnings Model
Lantern Pharma Inc. (LTRN) 3/30/2026 5:56:17 PM Micro View Financials 10-K SEC Y 2025 ending: 12/31/2025 Assets $11,035,811 EPS -$1.57
Lantern Pharma Inc. (LTRN) 11/13/2025 8:31:54 AM   View Financials Earnings SEC 3Q 2025 Assets $13,626,810 EPS -$0.39 Export Earnings Model
Lantern Pharma Inc. (LTRN) 11/12/2025 4:22:58 PM Micro View Financials 10-Q SEC 3Q 2025 ending: 9/30/2025 Assets $13,626,810 EPS -$0.39
Lantern Pharma Inc. (LTRN) 8/13/2025 4:17:19 PM   View Financials Earnings SEC 2Q 2025 Assets $17,420,292 EPS -$0.40 Export Earnings Model
Lantern Pharma Inc. (LTRN) 8/13/2025 4:14:22 PM Micro View Financials 10-Q SEC 2Q 2025 ending: 6/30/2025 Assets $17,420,292 EPS -$0.40
Lantern Pharma Inc. (LTRN) 8/8/2025 5:19:09 PM   View Proxy SEC Y 2024
Lantern Pharma Inc. (LTRN) 5/15/2025 8:46:14 AM Micro View Financials 10-Q SEC 1Q 2025 ending: 3/31/2025 Assets $21,096,335 EPS -$0.42
Lantern Pharma Inc. (LTRN) 5/15/2025 8:33:17 AM   View Financials Earnings SEC 1Q 2025 Assets $21,096,335 EPS -$0.42 Export Earnings Model
Lantern Pharma Inc. (LTRN) 4/30/2025 6:15:07 AM Micro View Financials 10-K/A SEC Y 2024 ending: 12/31/2024 Assets $25,571,792 EPS -$1.93
Lantern Pharma Inc. (LTRN) 3/27/2025 4:14:16 PM Micro View Financials 10-K SEC Y 2024 ending: 12/31/2024 Assets $25,571,792 EPS -$1.93
Lantern Pharma Inc. (LTRN) 3/27/2025 4:06:18 PM   View Financials Earnings SEC Y 2024 Assets $25,571,792 EPS -$0.54 Export Earnings Model
Lantern Pharma Inc. (LTRN) 11/7/2024 4:24:11 PM Micro View Financials 10-Q SEC 3Q 2024 ending: 9/30/2024 Assets $30,293,264 EPS -$0.42
Lantern Pharma Inc. (LTRN) 11/7/2024 4:07:52 PM   View Financials Earnings SEC 3Q 2024 Assets $30,293,264 EPS -$0.42 Export Earnings Model
Lantern Pharma Inc. (LTRN) 8/9/2024 4:02:41 AM Micro View Financials 10-Q SEC 2Q 2024 ending: 6/30/2024 Assets $35,586,929 EPS -$0.46
Lantern Pharma Inc. (LTRN) 8/8/2024 4:19:08 PM   View Financials Earnings SEC 2Q 2024 Assets $35,586,929 EPS -$0.46 Export Earnings Model
Lantern Pharma Inc. (LTRN) 5/9/2024 4:15:53 PM Micro View Financials 10-Q SEC 1Q 2024 ending: 3/31/2024 Assets $39,734,224 EPS -$0.51
Lantern Pharma Inc. (LTRN) 5/9/2024 4:08:52 PM   View Financials Earnings SEC 1Q 2024 Assets $39,734,224 EPS -$0.51 Export Earnings Model
Lantern Pharma Inc. (LTRN) 4/29/2024 7:30:56 AM   View Proxy SEC Y 2023
Lantern Pharma Inc. (LTRN) 3/18/2024 4:17:59 PM Micro View Financials 10-K SEC Y 2023 ending: 12/31/2023 Assets $43,647,616 EPS -$1.47
Lantern Pharma Inc. (LTRN) 3/18/2024 4:07:12 PM   View Financials Earnings SEC Y 2023 Assets $43,647,616 EPS -$0.39 Export Earnings Model
Lantern Pharma Inc. (LTRN) 11/8/2023 4:18:22 PM Micro View Financials 10-Q SEC 3Q 2023 ending: 9/30/2023 Assets $47,771,508 EPS -$0.29
Lantern Pharma Inc. (LTRN) 11/8/2023 4:07:10 PM   View Financials Earnings WIRE 3Q 2023 Assets $47,771,508 EPS -$0.29 Export Earnings Model
Lantern Pharma Inc. (LTRN) 11/8/2023 4:07:04 PM   View Financials Earnings SEC 3Q 2023 Assets $47,771,508 EPS -$0.29 Export Earnings Model
Lantern Pharma Inc. (LTRN) 8/9/2023 4:17:58 PM Micro View Financials 10-Q SEC 2Q 2023 ending: 6/30/2023 Assets $51,426,024 EPS -$0.44
Lantern Pharma Inc. (LTRN) 8/9/2023 4:07:59 PM   View Financials Earnings SEC 2Q 2023 Assets $51,426,024 EPS -$0.44 Export Earnings Model
Lantern Pharma Inc. (LTRN) 5/10/2023 4:01:26 AM Micro View Financials 10-Q SEC 1Q 2023 ending: 3/31/2023 Assets $55,509,317
Lantern Pharma Inc. (LTRN) 5/9/2023 4:10:14 PM   View Financials Earnings SEC 1Q 2023 Assets $55,509,317 Export Earnings Model
Lantern Pharma Inc. (LTRN) 4/28/2023 6:09:50 AM   View Proxy SEC Y 2022
Lantern Pharma Inc. (LTRN) 3/20/2023 4:20:30 PM Micro View Financials 10-K SEC Y 2022 ending: 12/31/2022 Assets $58,836,321
Lantern Pharma Inc. (LTRN) 3/20/2023 4:07:18 PM   View Financials Earnings SEC Y 2022 Assets $58,836,321 Export Earnings Model
Lantern Pharma Inc. (LTRN) 11/7/2022 4:19:19 PM Micro View Financials 10-Q SEC 3Q 2022 ending: 9/30/2022 Assets $62,164,380
Lantern Pharma Inc. (LTRN) 11/7/2022 4:07:44 PM   View Financials Earnings SEC 3Q 2022 Assets $62,164,380 Export Earnings Model
Lantern Pharma Inc. (LTRN) 8/8/2022 4:18:14 PM Micro View Financials 10-Q SEC 2Q 2022 ending: 6/30/2022 Assets $66,379,800
Lantern Pharma Inc. (LTRN) 8/8/2022 4:09:25 PM   View Financials Earnings SEC 2Q 2022 Assets $66,379,800 Export Earnings Model
Lantern Pharma Inc. (LTRN) 5/3/2022 4:18:19 PM Micro View Financials 10-Q SEC 1Q 2022 ending: 3/31/2022 Assets $68,402,517
Lantern Pharma Inc. (LTRN) 5/3/2022 4:05:12 PM   View Financials Earnings SEC 1Q 2022 Assets $68,402,517 Export Earnings Model
Lantern Pharma Inc. (LTRN) 4/27/2022 5:25:40 PM   View Proxy SEC Y 2021
Lantern Pharma Inc. (LTRN) 3/10/2022 4:23:55 PM Micro View Financials 10-K SEC Y 2021 ending: 12/31/2021 Assets $73,950,477
Lantern Pharma Inc. (LTRN) 3/10/2022 4:08:55 PM   View Financials Earnings SEC Y 2021 Assets $73,950,477 Export Earnings Model
Lantern Pharma Inc. (LTRN) 11/1/2021 4:15:01 PM Micro View Financials 10-Q SEC 3Q 2021 ending: 9/30/2021 Assets $77,606,197
Lantern Pharma Inc. (LTRN) 11/1/2021 4:07:10 PM   View Financials Earnings SEC 3Q 2021 Assets $77,606,197 Export Earnings Model
Lantern Pharma Inc. (LTRN) 7/29/2021 4:15:18 PM Micro View Financials 10-Q SEC 2Q 2021 ending: 6/30/2021 Assets $82,432,073
Lantern Pharma Inc. (LTRN) 7/29/2021 4:04:03 PM   View Financials Earnings SEC 2Q 2021 Assets $82,432,073 Export Earnings Model
Lantern Pharma Inc. (LTRN) 5/3/2021 4:14:34 PM   View Financials Earnings SEC 1Q 2021 Assets $82,504,659 Export Earnings Model
Lantern Pharma Inc. (LTRN) 5/3/2021 4:14:30 PM Micro View Financials 10-Q SEC 1Q 2021 ending: 3/31/2021 Assets $82,504,659
Lantern Pharma Inc. (LTRN) 4/9/2021 11:31:45 AM   View Proxy SEC Y 2020
Lantern Pharma Inc. (LTRN) 3/10/2021 4:12:05 PM Micro View Financials 10-K SEC Y 2020 ending: 12/31/2020 Assets $20,359,634 EPS -$1.37
Lantern Pharma Inc. (LTRN) 3/10/2021 4:03:30 PM   View Financials Earnings SEC Y 2020 Assets $20,359,634 EPS -$0.55 Export Earnings Model
Lantern Pharma Inc. (LTRN) 10/29/2020 4:14:14 PM Micro View Financials 10-Q SEC 3Q 2020 ending: 9/30/2020 Assets $22,492,952 EPS -$0.27
Lantern Pharma Inc. (LTRN) 10/29/2020 4:00:58 PM   View Financials Earnings SEC 3Q 2020 Assets $22,492,952 EPS -$0.27 Export Earnings Model
Lantern Pharma Inc. (LTRN) 7/30/2020 6:44:15 AM Micro View Financials 10-Q SEC 2Q 2020 ending: 6/30/2020 Assets $25,613,034 EPS -$0.31
Lantern Pharma Inc. (LTRN) 7/30/2020 6:33:52 AM   View Earnings SEC 2Q 2020 Assets $25,613,034 EPS -$0.31